# D3 Bio funding rounds and investors

As of 14 Oct 2026, D3 Bio has raised $108M across 1 verified round on record; latest: $108 million Series B, announced 9 Dec 2025.

D3 Bio develops innovative and efficacious medicines focused on oncology and immunology, targeting unmet patient needs.

Website: https://d3bio.com  
Page: https://fireround.dev/companies/d3bio.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-12-09 | Series B | $108 million | not stated | Corporate Venture Fund, HSG, IDG Capital, Medicxi, MPCi, SongQing Capital, Temasek | [prnewswire.com](https://www.prnewswire.com/news-releases/d3-bio-secures-108-million-in-series-b-financing-to-advance-global-clinical-programs-302636690.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.